Persistent abdominal or pelvic changes deserve an explanation. Ovarian cancer is one possible cause among many, and assessment combines your history, examination and appropriate tests. This guide helps you prepare for that assessment and understand the decisions that follow a concerning result.
Describe the pattern of symptoms
The NCI ovarian-cancer overview lists abdominal pain or swelling, pelvic discomfort, difficulty eating or feeling full, and bowel changes among possible symptoms. Urinary changes may also need assessment. Arrange an appointment for new symptoms that persist, worsen or keep returning, and tell the clinician what is different from your usual pattern.
Make a short record: when the change began, how often it happens, whether it affects eating or daily activities, and any bleeding, bowel or urinary changes. Include menopausal status, previous operations and medicines. The record supports a conversation; avoid delaying an appointment while trying to collect a perfect diary.
If the initial explanation or treatment does not resolve the problem, ask when to return and which changes should prompt an earlier call. Persistent symptoms deserve follow-up even when an initial test is reassuring. Severe or rapidly worsening symptoms need urgent clinical assessment.
Know what each test contributes
On a small screen, scroll the table sideways. Keyboard users can focus the table region and use the arrow keys.
| Assessment | What it contributes | Question to clarify |
|---|---|---|
| History and examination | Identify symptom patterns and findings that guide testing. | What possible causes are being considered? |
| Pelvic ultrasound or other imaging | Describe an abnormality, its location and features. | What needs further investigation or specialist review? |
| CA-125 blood test | Adds information interpreted with symptoms, imaging and history. | How does this result affect the next step? |
| Tissue examination | Establishes the diagnosis and cancer type. | How and when will tissue be obtained and reviewed? |
A clinician may recommend pelvic ultrasound, including a transvaginal scan, and other imaging when needed. Ask how the examination will be performed, what consent and comfort options are available, and whether alternatives are suitable. A scan can describe a mass while leaving questions about its nature.
MedlinePlus explains CA-125 as a blood marker used in several settings, including evaluating a concerning pelvic finding and monitoring known cancer. Menstruation, endometriosis and other noncancerous conditions can raise it. Some ovarian cancers do not produce a high result. A high value needs context; a normal value does not rule out cancer.
A platelet count or other routine blood result cannot supply a stand-alone ovarian-cancer diagnosis or personal prognosis. Ask the clinician to explain the combined evidence. When an ovarian malignancy is suspected, ask whether a gynecologic oncologist should help plan tissue diagnosis and surgery. The tissue may be obtained during surgery or through a separately planned procedure.
Separate symptoms from routine screening
NCI’s screening review describes the lack of an established population screening approach that has been shown to reduce deaths from ovarian cancer. Testing people without symptoms can lead to false alarms and invasive procedures. That evidence does not remove the need to investigate symptoms or a pelvic mass.
For someone at average risk without symptoms, an annual CA-125 test or ultrasound should not be treated as a reliable reassurance package. A cervical HPV or Pap test addresses cervical disease; it is not an ovarian-cancer screening test. Ask what a proposed test is intended to find and what happens after an abnormal result.
Bring family history into the discussion
Record which relatives had cancer, the cancer type and their age at diagnosis, on both sides of the family. Bring any actual genetic-test report if available. Patterns involving ovarian, breast, pancreatic, prostate or colorectal cancers can affect a genetic-risk discussion, depending on the details.
NCI’s inherited-cancer testing guidance explains the role of counseling and the different meanings of positive, negative and uncertain results. A strong inherited-risk concern calls for an individualized plan, including discussion of risk-reducing options; routine screening alone may leave important risk unaddressed.
If ovarian cancer is diagnosed, ask which inherited and tumor tests are indicated. BRCA and other findings can matter for treatment and relatives’ care. Tumor testing and inherited testing may overlap in what they detect, but answer different questions; the team should explain whether a finding needs confirmation in a blood or saliva sample.
Prepare your records with the family-history and genetic testing guide, including a worksheet for the counseling visit.
Understand the specialist plan
Ask for the exact pathology diagnosis. Epithelial ovarian, fallopian-tube and primary peritoneal cancers are often discussed together, while germ-cell and stromal tumors have different care pathways. The stage describes extent; tumor type, grade, molecular findings, general health and surgical assessment also influence treatment.
For epithelial disease, treatment often combines surgery and systemic medicines. Sometimes surgery comes first; sometimes medicines precede surgery. Ask why the sequence fits your situation, what surgery aims to accomplish and which findings could change the plan. A marker result alone does not choose that sequence.
Before treatment, discuss fertility or early-menopause concerns when relevant, symptom relief, nutrition, practical support and whether a second opinion or trial discussion would be useful. Ask how response and side effects will be assessed. Current options are summarized in the NCI treatment overview linked above.
The cancer-staging explainer can help you organize questions about the terms in your specialist’s report.
Prepare a focused appointment record
- Symptom onset, frequency, changes and effects on daily life.
- Examination, imaging and laboratory reports with dates and exact wording.
- Family cancer history and any genetic reports.
- The next test or referral, its purpose and who arranges it.
- When results are expected, who explains them and when to return if symptoms continue.
Repeat the agreed next step in your own words before leaving. For the separate cervical pathway, see HPV, cervical screening results and follow-up.
Updated October 9, 2026. General education for conversations with qualified health professionals; individual care depends on your history, results and local guidance.
Explore the Cancer guides and topic directory.